Shukra Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 36 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and UZPHARM (UZ). Its GMP standing is certified by CDSCO (India), FDA (GH) and NAFDAC (NG). Customs aggregates show $167K of exports covering 28 molecules to 5 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ahmedabad, India | 3042700568 |
| Plot No., India | Not on file |
| tal kalolrakanpurgand hinagar, India | Not on file |
| Gandhinagar, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 21 | 1 |
| FDA (GH) | 14 | 1 |
| UZPHARM (UZ) | 1 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $142K | 2 |
| 2025 | Not reported | $167K | 5 |
| 2024 | Not reported | $66 | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Shukra Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free